Found 10 results
Author Title Type [ Year(Desc)]
Filters: Author is Young, Lowell S  [Clear All Filters]
2003
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., “Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.”, Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.
2004
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
G. Carter, Young, L. S., and Bermudez, L. E., “A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.”, Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.
2005
L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrobial agents and chemotherapy, vol. 49, no. 9, pp. 3707-14, 2005.
L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., “Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.”, Antimicrob Agents Chemother, vol. 49, no. 9, pp. 3707-14, 2005.
2006
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microb Drug Resist, vol. 12, no. 1, pp. 1-6, 2006.
L. Danelishvili, Young, L. S., and Bermudez, L. E., “In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium.”, Microbial drug resistance (Larchmont, N.Y.), vol. 12, no. 1, pp. 1-6, 2006.
2007
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., “EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
2012
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., “Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”, Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.